Antiepileptogenesis and disease modification: Clinical and regulatory issues.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jacqueline A,French

第一单位： NYU Grossman School of Medicine and NYU Langone Health, New York, NY, USA.

作者： Jacqueline A,French ^[1] ; Martina,Bebin ^[2] ; Marc A,Dichter ^[3] ; Jerome,Engel ^[4] ; Adam L,Hartman ^[5] ; Sergiusz,Jóźwiak ^[6] ; Pavel,Klein ^[7] ; James,McNamara ^[8] ; Roy,Twyman ^[9] ; Paul,Vespa ^[10]

作者单位： NYU Grossman School of Medicine and NYU Langone Health, New York, NY, USA. ^[1] UAB School of Medicine and UAB Epilepsy Center, Birmingham, AL, USA. ^[2] University of Pennsylvania, Philadelphia, PA, USA. ^[3] David Geffen School of Medicine at, UCLA and the Brain Research Institute, Los Angeles, CA, USA. ^[4] Division of Clinical Research, National Institute of Neurological Disorders and Stroke/NIH, Bethesda, MD, USA. ^[5] Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland. ^[6] Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA. ^[7] Department of Neurobiology, Duke University School of Medicine, Durham, NC, USA. ^[8] Amron Neuroscience, LLC, Darby, MT, USA. ^[9] Departments of Neurology and Neurosurgery, David Geffen School of Medicine UCLA, Los Angeles, CA, USA. ^[10]

关键词 antiepileptogenesis clinical trials disease modification

主题词成年人(Adult);抗惊厥药(Anticonvulsants);儿童(Child);癫痫(Epilepsy);人类(Humans);美国(United States);氨己烯酸(Vigabatrin)

DOI 10.1002/epi4.12526

PMID 34270884

发布时间 2022-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Epilepsia open

2021年6卷3期

483-492页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Antiepileptogenesis and disease modification: Clinical and regulatory issues.

Epilepsia open

相似文献

Epilepsia open

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Antiepileptogenesis and disease modification: Clinical and regulatory issues.

Epilepsia open

相似文献

Epilepsia open

相关期刊

检索历史清除